Portfolio company
OctoVascular
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
OctoVascular develops automated vessel connection technology for surgeons to perform minimally invasive coronary artery bypass surgery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Vascular Graft Solutions
This company develops external support devices and surgical tools for vein grafts to improve outcomes in coronary and peripheral bypass surgeries for cardiac surgeons.
AMT-Medical
AMT-Medical develops a minimally invasive heart bypass system for cardiac surgeons to replace open-heart surgery with catheter-based and laser-assisted procedures.
CorInnova
The company develops a minimally invasive cardiac assist device to treat patients with acute heart failure without contacting the blood.
Artifex
This company develops artificial vascular grafts for patients undergoing coronary and peripheral bypass surgery.
iCHOR Vascular
This company develops minimally invasive mechanical thrombectomy devices for clinicians to remove blood clots from peripheral arteries and veins.
ENDOVASCULAR DEVICES
This company develops minimally invasive vessel preparation tools to treat peripheral artery disease and failed arteriovenous fistulas for interventional clinicians.
CardioMech
CardioMech develops a transcatheter-based artificial chordae delivery system for hospitals to treat patients suffering from degenerative mitral regurgitation without open-heart surgery.
Nitiloop
Nitiloop develops vascular microcatheters for cardiologists and surgeons to treat chronic total occlusions and other complex lesions within coronary and peripheral vasculature.